Paolo Daniele Siviero

Xyence Capital SGR (Xyence Capital) is a venture capital firm founded in 2002 by Stefano Peroncini and Pierluigi Paracchi. The firm is headquartered in Milano, Italy.

IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France.

WISE Srl operates as a biomedical company which engages in the development of neuromodulation and neuromonitoring devices. It offers scbi technology, stretchability, micropatterning, biocompatibility and effective stimulation. The company was founded by Cristian Ghisleri, Luca Ravagnan, Mario Zanone Poma and Paolo Milani in 2011 and is headquartered in Cologno Monzese, Italy.

Xyence Capital SGR (Xyence Capital) is a venture capital firm founded in 2002 by Stefano Peroncini and Pierluigi Paracchi. The firm is headquartered in Milano, Italy.

WISE Srl operates as a biomedical company which engages in the development of neuromodulation and neuromonitoring devices. It offers scbi technology, stretchability, micropatterning, biocompatibility and effective stimulation. The company was founded by Cristian Ghisleri, Luca Ravagnan, Mario Zanone Poma and Paolo Milani in 2011 and is headquartered in Cologno Monzese, Italy.

WISE Srl operates as a biomedical company which engages in the development of neuromodulation and neuromonitoring devices. It offers scbi technology, stretchability, micropatterning, biocompatibility and effective stimulation. The company was founded by Cristian Ghisleri, Luca Ravagnan, Mario Zanone Poma and Paolo Milani in 2011 and is headquartered in Cologno Monzese, Italy.

IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France.

IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France.

IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France.

IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France.

IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France.

WISE Srl operates as a biomedical company which engages in the development of neuromodulation and neuromonitoring devices. It offers scbi technology, stretchability, micropatterning, biocompatibility and effective stimulation. The company was founded by Cristian Ghisleri, Luca Ravagnan, Mario Zanone Poma and Paolo Milani in 2011 and is headquartered in Cologno Monzese, Italy.

IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France.

WISE Srl operates as a biomedical company which engages in the development of neuromodulation and neuromonitoring devices. It offers scbi technology, stretchability, micropatterning, biocompatibility and effective stimulation. The company was founded by Cristian Ghisleri, Luca Ravagnan, Mario Zanone Poma and Paolo Milani in 2011 and is headquartered in Cologno Monzese, Italy.

WISE Srl operates as a biomedical company which engages in the development of neuromodulation and neuromonitoring devices. It offers scbi technology, stretchability, micropatterning, biocompatibility and effective stimulation. The company was founded by Cristian Ghisleri, Luca Ravagnan, Mario Zanone Poma and Paolo Milani in 2011 and is headquartered in Cologno Monzese, Italy.

IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France.

IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France.

WISE Srl operates as a biomedical company which engages in the development of neuromodulation and neuromonitoring devices. It offers scbi technology, stretchability, micropatterning, biocompatibility and effective stimulation. The company was founded by Cristian Ghisleri, Luca Ravagnan, Mario Zanone Poma and Paolo Milani in 2011 and is headquartered in Cologno Monzese, Italy.

IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France.